GeneFab
Michelle Hung is a Principal Scientist at GeneFab since August 2023. Prior to that, Michelle worked at Senti Biosciences from April 2019 to August 2023 as a Principal Scientist in Gene Circuit Discovery, where Michelle led collaborations to build gene circuit enabled cell therapies for regenerative medicine. Michelle also has experience at AbbVie, where Michelle was a Senior Scientist II working on bispecific ADC and novel ADC formats. Their educational background includes a Ph.D. in Biology/Biological Sciences from Northwestern University and a Management for Scientists Certificate from Northwestern University - Kellogg School of Management.
GeneFab
GeneFab offers its customers an extensive technology platform and know-how that spans early stage product design, technical development, and cGMP compliant production. GeneFab's technology platform includes bioinformatic-guided discovery of cell type promoters, directed evolution of small molecule-regulated gene switches, and the engineering of highly sensitive kill switches for enhanced safety and control of cellular therapies.